Literature DB >> 8879197

Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands.

G J Kersh1, P M Allen.   

Abstract

T cells recognize short linear peptides bound to major histocompatibility complex (MHC)-encoded molecules. Subtle molecular changes in peptide antigens produce altered peptide ligands (APLs), which induce different T cell responses from those induced by the antigenic ligand. A molecular basis for how these slight molecular variations lead to such different consequences for the T cell has not been described. To address this issue, we have made amino acid substitutions at the primary T cell receptor (TCR) contact residue of the murine hemoglobin determinant, Hb(64-76)/I-Ek and produced 12 peptides that interact with the TCR of the T cell clone 3.L2. The 3.L2 T cell responds to these peptides, which vary 1 million-fold in their activity, and enables them to be ranked according to their relative ability to signal through the 3.L2 TCR. Such a ranking reveals that the ability of the 3.L2 T cell to respond to these peptides depends on how well the structure of the side chain at the primary TCR contact site mimics that of the Asn residue present in the antigenic ligand. The reactivity of the 3.L2 T cell also depends on an MHC contact residue that is next to the primary TCR contact residue, suggesting that conformation of the Asn side chain is also important. By using nonnatural amino acids at a TCR contact residue, we have demonstrated that APLs can be rationally designed based on structure. These data are consistent with a model in which the affinity of a peptide-MHC complex for the TCR determines how the T cell will respond.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879197      PMCID: PMC2192852          DOI: 10.1084/jem.184.4.1259

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas.

Authors:  B D Evavold; S G Williams; B L Hsu; S Buus; P M Allen
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

2.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists.

Authors:  D S Lyons; S A Lieberman; J Hampl; J J Boniface; Y Chien; L J Berg; M M Davis
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

4.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

5.  Binding of immunogenic peptides to Ia histocompatibility molecules.

Authors:  B P Babbitt; P M Allen; G Matsueda; E Haber; E R Unanue
Journal:  Nature       Date:  1985 Sep 26-Oct 2       Impact factor: 49.962

6.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  Antimetabolites produced by microorganisms. II. L-2-amino-4-pentynoic acid.

Authors:  J P Scannell; D L Pruess; T C Demny; F Weiss; T Williams
Journal:  J Antibiot (Tokyo)       Date:  1971-04       Impact factor: 2.649

8.  Analogs that compete for antigen binding to an arsonate-reactive T-cell clone inhibit the functional response to arsonate.

Authors:  A Rao; S J Faas; H Cantor
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

9.  Binding of antigen in the absence of histocompatibility proteins by arsonate-reactive T-cell clones.

Authors:  A Rao; W W Ko; S J Faas; H Cantor
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

10.  Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.

Authors:  B D Evavold; P M Allen
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

View more
  46 in total

1.  The lack of consensus for I-A(g7)-peptide binding motifs: is there a requirement for anchor amino acid side chains?

Authors:  E Carrasco-Marin; O Kanagawa; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c-I-E(k).

Authors:  Evan W Newell; Lauren K Ely; Andrew C Kruse; Philip A Reay; Stephanie N Rodriguez; Aaron E Lin; Michael S Kuhns; K Christopher Garcia; Mark M Davis
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

Review 3.  Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.

Authors:  Halina Offner; Sushmita Sinha; Chunhe Wang; Gregory G Burrows; Arthur A Vandenbark
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

Review 4.  T cell receptor antagonism in vivo, at last.

Authors:  S C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 5.  Improving T cell responses to modified peptides in tumor vaccines.

Authors:  Jonathan D Buhrman; Jill E Slansky
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

6.  Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.

Authors:  Rachel H McMahan; Jennifer A McWilliams; Kimberly R Jordan; Steven W Dow; Darcy B Wilson; Jill E Slansky
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

7.  Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis.

Authors:  Jan D Lünemann; Harald Gelderblom; Mireia Sospedra; Jacqueline A Quandt; Clemencia Pinilla; Adriana Marques; Roland Martin
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

Review 8.  Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis.

Authors:  Laura Mandik-Nayak; Paul M Allen
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

9.  In vivo antagonism of a T cell response by an endogenously expressed ligand.

Authors:  D Basu; C B Williams; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands.

Authors:  Liliana G Petrich de Marquesini; Antonis K Moustakas; Ian J Thomas; Li Wen; George K Papadopoulos; F Susan Wong
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.